Search the Newsreel

Die Bristol-Myers-Squibb-Aktie legt nach starken Quartalszahlen zu

Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing …

Die Bristol-Myers-Squibb-Aktie profitiert von FDA-Zulassung und solider Prognose

Die Bristol-Myers-Squibb-Aktie legt nach starken Q2-Zahlen und neuer Zahlung zu

Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

Key Points Earlier this month, AstraZeneca and Bristol Myers Squibb became the subject of merger rumors. Investors reacted negatively to the rumors, even if on paper such a deal would create an oncology-focused big pharma powerhouse worth around $400 billion. Considering regulatory uncertainty and …

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Product Image (Photo: Bristol Myers Squibb)ZENBEXUS™ (iberdomide) Logo Approval based on EXCALIBER-RRMM results showing ZDd doubled minimal residual disease-negative complete response rates versus daratumumab, bortezomib and dexamethasone (41% vs. 21%) in relapsed or refractory multiple myeloma(1) ZENBEXUS marks the arrival of a new treatment …

Die Bristol-Myers-Squibb-Aktie steigt nach Konsensstärke und solider Dividendenrendite

Is Bristol Myers’ US$2.3 Billion Houston Manufacturing Campus Altering The Investment Case For BMY?

Bristol Myers Squibb recently announced it will invest about US$2.30 billion in a new 600,000-square-foot modular, multi-modal manufacturing campus at Generation Park in Houston, Texas, expected to support production of small molecules, biologics, and antibody-drug conjugates while creating nearly 500 skilled jobs and about …

BRISTOL-MYERS SQUIBB AKTIE: AI-Analysen, Prognose & Kursziel

Bristol Myers Squibb to build $2.3 billion Houston campus

Bristol Myers Squibb announced Monday it will build a $2.3 billion drug manufacturing campus in Houston, Texas, part of the company's broader $40 billion commitment to invest in the United States over five years. The roughly 600,000-square-foot campus will be located at Generation Park, …

Bristol Myers To Invest $2.3 Bln In Houston Manufacturing Campus; To Create 500 Skilled Jobs

(RTTNews) - Bristol Myers Squibb (BMY) announced Monday an investment of approximately $2.3 billion in the U.S., while selecting Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus to accelerate the delivery of next-generation medicines to patients. The approximately 600,000 square …

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

New State-of-the-Art Facility Will Create Nearly 500 Skilled Jobs and Accelerate the Delivery of Next-Generation Medicines Investment Furthers BMS' $40 Billion Commitment to American Innovation, Manufacturing and Economic Growth PRINCETON, N.J., August 10, 2026--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, …

BioNTech Aktie: 613 Millionen von Bristol Myers Squibb erwartet

Bristol-Myers-Squibb-Aktie bleibt nach Zahlen und Pipeline-Kurs im Blick

Bristol-Myers Squibb Co (BMY) Aktienanalyse & Prognose

Bristol-Myers Squibb Co (BMY) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

BioNTech Aktie: BNT327 mit Bristol Myers Squibb

Bristol Myers Squibb erhöht die Prognose für 2026 nach besser als erwarteten Ergebnissen im zweiten Quartal.

Bristol Myers Squibb hebt Prognose an nach Wachstumsschub - Aktie steigt vorbörslich

BRAGA MORO SISTEMI DI ENERGIA S.P.A.

Azioni Braga Moro Sistemi di Energia S.p.A. (BRM) - Quotazioni Borsa Italiana

Pharma-Dividenden als Rentenbaustein: Bristol-Myers Squibb, Novo Nordisk und Merck

Bristol-Myers Squibb übertrifft im ersten Quartal 2026 die Gewinn- und Umsatzerwartungen

Bristol-Myers Squibb Aktie: FDA-Durchbruch

Braga Moro chiude il semestre in forte crescita e consolida la strategia di espansione internazionale

Bristol Myers Squibb: Prognose erhöht, KGV 7 – ist die Aktie jetzt ein Kauf?

Bristol-Myers Squibb Aktie | US1101221083 | ETR:BRM | News & Aktienkurs | FRA:BRM

BRISTOL-MYERS SQUIBB AKTIE | BRM | Aktienkurs | US1101221083 | News | 850501